Facetten
Zugriff
Einrichtung
Medientyp
- Text 11
Karte
Erscheinungsjahr
Autor/in
- Lauseker, Michael
- Fabarius, Alice 4
- Haferlach, Claudia 4
- Hehlmann, Rüdiger 4
- Kalmanti, Lida 4
- alle zeigen
Sprache
11 Einträge gefunden
-
Medication Adherence in a Cross-Diagnostic Sample of Patients From the Affective-to-Psychotic Spectrum: Results From the PsyCourse Study
- Kirchner, Sophie-Kathrin
- Lauseker, Michael
- Adorjan, Kristina
- Anderson-Schmidt, Heike
- Anghelescu, Ion-George
- Baune, Bernhardt T
- Budde, Monika
-
-
-
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV
- Michel, Christian
- Burchert, Andreas
- Hochhaus, Andreas
- Saussele, Susanne
- Neubauer, Andreas
- Lauseker, Michael
- Krause, Stefan W
-
-
The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models
- Nölting, Svenja
- Rentsch, Jakob
- Freitag, Helma
- Detjen, Katharina
- Briest, Franziska
- Möbs, Markus
- Weissmann, Victoria
-
Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV
- Hehlmann, Rüdiger
- Müller, Martin C
- Lauseker, Michael
- Hanfstein, Benjamin
- Fabarius, Alice
- Schreiber, Annette
- Proetel, Ulrike
-
Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV
- Proetel, Ulrike
- Pletsch, Nadine
- Lauseker, Michael
- Müller, Martin C
- Hanfstein, Benjamin
- Krause, Stefan W
- Kalmanti, Lida
-
Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV
- Kalmanti, Lida
- Saussele, Susanne
- Lauseker, Michael
- Proetel, Ulrike
- Müller, Martin C
- Hanfstein, Benjamin
- Schreiber, Annette
-
Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia.
- Hehlmann, Rüdiger
- Lauseker, Michael
- Jung-Munkwitz, Susanne
- Leitner, Armin
- Müller, Martin C
- Pletsch, Nadine
- Proetel, Ulrike
-
Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV.
- Saussele, Susanne
- Lauseker, Michael
- Gratwohl, Alois
- Beelen, Dietrich W
- Bunjes, Donald
- Schwerdtfeger, Rainer
- Kolb, Hans-Jochem